Daxor Corporation (DXR)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jonathan Adam Feldschuh | Chief Scientific Officer & Director | 127.92k | -- | 1965 |
| Mr. Michael Richard Feldschuh | Chairman, President & CEO | 100k | -- | 1969 |
| Mr. Robert J. Michel C.P.A., CPA, M.B.A. | CFO, Chief Compliance Officer & Corporate Secretary | -- | -- | 1957 |
| Ms. Linda Cooper | Vice President of Development & Operations | -- | -- | -- |
| Ms. Kathryn A. Kornafel | Senior VP of Marketing & Commercial Development | -- | -- | -- |
| Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. | Chief Medical Officer | -- | -- | -- |
Daxor Corporation
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Corporate Governance
Upcoming Events
March 6, 2025 at 9:00 PM UTC
Daxor Corporation Earnings Date
Recent Events
March 14, 2025 at 12:00 AM UTC
N-CEN: Annual Report for Registered Investment Companies
January 22, 2025 at 12:00 AM UTC
NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)
November 21, 2024 at 12:00 AM UTC
NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)
September 10, 2024 at 12:00 AM UTC
N-PX: Annual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX
August 29, 2024 at 12:00 AM UTC
NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)
August 23, 2024 at 12:00 AM UTC
40-17G: Fidelity bond filed pursuant to Rule 17g1(g)(1) of the Investment Company Act of 1940